← Patent-cliff monitor A biotechnology company with a focus on treatments for neurological and neurodegenerative diseases. It was founded in 1978 and has headquarters in Cambridge, Massachusetts.
Company Company Operating Status Active Crunchbase URL https://www.crunchbase.com/organization/biogen-idec Facebook URL https://www.facebook.com/biogenjapan Full Address 225 Binney Street Cambridge, MA 02142, USA Instagram URL https://www.instagram.com/biogenjapan Legal Entity Identifier W8J5WZB5IY3K0NDQT671 LinkedIn URL http://linkedin.com/company/biogen- Pitchbook URL https://pitchbook.com/profiles/company/10553-05
17 upcoming patent cliffs Drug Ingredient Type Cliff
Avonex interferon beta-1a Biologic May 2015 Tysabri natalizumab Biologic Nov 2016 Avonex interferon beta-1a Biologic Feb 2024 Plegridy peginterferon beta-1a Biologic Aug 2026 Plegridy peginterferon beta-1a Biologic Aug 2026 Plegridy peginterferon beta-1a Biologic Aug 2026 Plegridy peginterferon beta-1a Biologic Aug 2026 Plegridy peginterferon beta-1a Biologic Aug 2026 Plegridy peginterferon beta-1a Biologic Aug 2026 SPINRAZA NUSINERSEN SODIUM Small mol. Dec 2030 SPINRAZA NUSINERSEN SODIUM Small mol. Dec 2030 Aduhelm aducanumab-avwa Biologic Jun 2033 Aduhelm aducanumab-avwa Biologic Jun 2033 VUMERITY DIROXIMEL FUMARATE Small mol. Oct 2033 TECFIDERA DIMETHYL FUMARATE Small mol. Nov 2035 TECFIDERA DIMETHYL FUMARATE Small mol. Nov 2035 SPINRAZA NUSINERSEN SODIUM Small mol. Mar 2036 ZURZUVAE ZURANOLONE Small mol. Aug 2037 ZURZUVAE ZURANOLONE Small mol. Aug 2037 ZURZUVAE ZURANOLONE Small mol. Aug 2037 Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.